Results 1 to 10 of about 138 (63)
Predoperativna radiokemoterapija pri bolnikih z neresektabilnim karcinomom želodca
Onkologija, 2009 Osnovno zdravljenje karcinoma želodca je radikalna resekcija. Ob postavitvi diagnoze je bolezen neresktabilna pri približno 50 % bolnikov. Znano je, da predoperativna radiokemoterapija lahko zmanjša tumor, kar povečuje možnost radikalne resekcije in ...
Ana Jeromen +4 more
doaj +3 more sources
[The radiation therapy practitioner\u27s view of oesophageal cancer treatment] [PDF]
, 2018 Karcinom požiralnika je bolezen, katere incidenca po svetu narašča in katere prognoza je praviloma, kljub vsemu doseženemu napredku v onkologiji v zadnjih letih, še vedno slaba.
Anderluh, Franc
core +1 more source
15th World Congress on Gastrointestinal Cancer [PDF]
, 2018 The 15th World Congress on Gastrointestinal Cancer took place from 3 to 6 July 2013 in Barcelona. This is a global event addressing individual types of gastrointestinal cancer in accordance with the latest recommendations and findings, from diagnosis to ...
Oblak, Irena, Potrč, Stojan
core +1 more source
Immunotherapy for squamous cell carcinoma of the head and neck - experience from Slovenia [PDF]
, 2021 Izhodišča: Imunoterapija z zaviralcem imunskih kontrolnih točk nivolumabom, zaviralnim protitelesom proti proteinu programirane celične smrti 1 (PD-1), je za bolnike z neozdravljivo ponovitvijo bolezni ali sistemskimi zasevki ploščatoceličnega karcinoma ...
Azarija, Jelena +3 more
core +1 more source
[The radiation therapy oncologist\u27s view of gastric cancer treatment] [PDF]
, 2018 Gastric cancer is associated with a poor prognosis. At diagnosis, approximately 50% of patients have a non-resectable disease. In patients who underwent radical resection, the disease recurs in as many as 75%, of which 40-64% are local and/or regional ...
Oblak, Irena
core +1 more source
Pogled radioterapevta onkologa na zdravljenje raka želodca [PDF]
, 2014 Gastric cancer is associated with a poor prognosis. At diagnosis, approximately 50% of patients have a non-resectable disease. In patients who underwent radical resection, the disease recurs in as many as 75%, of which 40-64% are local and/or regional ...
Oblak, Irena
core +1 more source
Pogled internista onkologa na zdravljenje raka želodca
Onkologija, 2014 Veliko število bolnikov s karcinomom želodca (KŽ) in gastroezofegealnega prehoda (GEP) ima ponovitev bolezni po resekciji. Ponovitve so lokalne ali z oddaljenimi zasevki ali pa kombinacija obojega.
Janja Ocvirk
doaj
16. svetovni kongres o raku prebavil [PDF]
, 2015 The 16th World Congress on Gastrointestinal Cancer took place in Barcelona from 25 to 28 June 2014. The congress was attended by general practitioners, gastroenterologists, hepatologists, internist oncologists, surgeons and different researchers, who ...
Benedik, Jernej, Oblak, Irena
core +1 more source
Ali imajo tarčna zdravila svoje mesto v radiokemoterapiji tumorjev prebavil?
Onkologija, 2014 V zadnjem desetletju smo priča hitremu napredku v razumevanju tumorske biologije in imunologije rakov prebavil. Sočasno je prišlo do izboljšav v tehnikah obsevanja, zaradi katerih je lokalna kontrola bolezni boljša, saj je lahko doza na tumor večja ...
Vaneja Velenik
doaj
Predoperativno obsevanje pri bolnici z rakom želodca
Onkologija, 2014 Pri bolnikih z neresektabilnim oz. mejno resektabilnim rakom želodca, ki nimajo razsoja bolezni, priporočamo predoperativno radiokemoterapijo, s katero poskušamo zmanjšati tumor in s tem zvišati možnost popolne odstranitve (R0 resekcija).
Ajra Šečerov Ermenc, avtor
doaj